secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker MMSI CIK 0000856982
leadership confidence high sentiment neutral materiality 0.55

Merit Medical appoints Joe Wright President; Lampropoulos remains CEO

MERIT MEDICAL SYSTEMS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Fred P. Lampropoulos

President
MMSI · MERIT MEDICAL SYSTEMS INC
Effective
2024-05-15
Successor
Joseph C. Wright
Filed
May 16, 2024, 7:59 PM ET
In connection with Mr. Wright’s appointment, Fred P. Lampropoulos resigned as President of Merit. Mr. Lampropoulos will continue to serve as Merit’s Chief Executive Officer.
Appointed

Joseph C. Wright

President
MMSI · MERIT MEDICAL SYSTEMS INC
Effective
2024-05-15
Filed
May 16, 2024, 7:59 PM ET
The Board of Directors of Merit Medical Systems, Inc. (“Merit”) appointed Joseph C. Wright as President of Merit, effective as of May 15, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Fred P. Lampropoulos resigned as President at MERIT MEDICAL SYSTEMS INC.

Action
resigned
Role
President
Exact text from the filing
In connection with Mr. Wright’s appointment, Fred P. Lampropoulos resigned as President of Merit. Mr. Lampropoulos will continue to serve as Merit’s Chief Executive Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph C. Wright was appointed as President at MERIT MEDICAL SYSTEMS INC.

Action
appointed
Role
President
Exact text from the filing
The Board of Directors of Merit Medical Systems, Inc. (“Merit”) appointed Joseph C. Wright as President of Merit, effective as of May 15, 2024.
View on SEC.gov

MERIT MEDICAL SYSTEMS INC filing history →

Source: SEC EDGAR
accession 0000856982-24-000045
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.